Roche looks to Brazil for R&D
This article was originally published in Scrip
Executive Summary
Rocheis to screen the Brazilian biotech sector for potential R&D partnerships, the company has told Scrip. Fundação Biominas, a private institution specialising in promoting "bio-business" in Brazil, has been contracted by Roche Brazil to identify opportunities in the country. Areas of interest will include oncology, inflammatory diseases, virology and central nervous system diseases, which make up the company's core business.